Clinical Trial Update: A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety and efficacy of DE-101 ophthalmic suspension for Dry Eye Disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• DE-101 ophthalmic suspension (DE-101)

Snippet

Sponsor: Santen Inc. | Conditions: Dry Eye Disease | Phase 2 | Status: COMPLETED